PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

Clinical trial NCT05190172 · RECRUITING

Trial details

NCT number: NCT05190172
Sponsor: Oslo University Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Oligodendroglioma Oligodendroglioma, Anaplastic Diffuse Astrocytoma, IDH-Mutant

Start date: 2022-01-14
Primary completion: 2030-12-31
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.